Alcon AcrySof Intraocular Lens

Alcon is a global leader in eye care, renowned for its advanced intraocular lenses (IOLs) like the AcrySof IQ series, which are used to replace the natural lens during cataract surgery. These precision-engineered medical devices are designed to improve visual acuity and treat conditions like presbyopia and astigmatism.

Originally founded in Texas, USA, Alcon has evolved from a small pharmacy into a global surgical and vision care powerhouse. While the brand spent several decades under the ownership of Nestlé and later Novartis, it successfully completed a spin-off in 2019 to become an independent, publicly-traded company. Today, Alcon maintains a massive manufacturing footprint, with major production facilities in the United States, Ireland, and Singapore to meet the global demand for surgical ophthalmology products.

As of 2026, Alcon operates as an independent entity, focusing exclusively on eye care innovation. It is headquartered in Switzerland while maintaining its primary operational hub in Fort Worth, Texas, solidifying its status as a key player in the global medical technology market.